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Broad- and narrow-spectrum antibiotics: a different 
approach 
Clin Microbiol Infect 1998; 4: 56-57 
We welcome the comment of Dr Acar (Clin Microbiol 
Infect 1997; 3: 395-6) questioning a lifetime usage of 
the terms ‘broad- and narrow-spectrum antibiotics’. It 
appears he now realizes that there is no clear definition 
of these terms and he boldly suggests that we cease 
using them. We agree whole-heartedly. We adopt a 
different approach to antibiotic usage which Dr Acar 
may find more understandable and acceptable. 
Traditionally, microorganisms are categorized using 
the Gram stain. Antibiotics can be classified by their 
activity against a spectrum of microorganisms. The 
more species of organisms that are killed, the broader is 
the spectrum of activity. Antibiotics only active against 
Gram-positive bacteria such as flucloxacillin, are narrow 
in their spectrum, whilst antibiotics capable of lulling 
both Gram-positive and Gram-negative bacteria, such 
as cephradine, are broad in their activity [l]. 
We advocate describing antibiotic activity accord- 
ing to the intrinsic pathogenicity of the micro- 
organism targeted by the antibiotic rather than its 
Gram stain. The ratio between the number of patients 
infected by a particular microorganism and the number 
of patients carrying that organism in throat and/or gut 
i r  defined as the intrinsic pathogenicity index (IPI) for 
a particular microorganism [2]. The patient’s carrier 
state allows us to classify the microorganisms into three 
groups. Indigenous flora, including anaerobes and 
viridans streptococci, are low-level pathogens and 
rarely cause infections despite being carried in high 
concentrations (IPI between 0.01 and 0.03). High-level 
pathogens such as Salmonella species have an IPI 
approaching 1 .O. We have identified about 14 potential 
pathogens characterized by IPIs between 0.1 and 0.3. 
Out of 10 patients who carry potentially pathogenic 
microorganisms (PPM), one, two or three may develop 
one or more infections with these PPMs. We make a 
distinction between ‘community’ and ‘hospital’ PPMs 
depending on the severity of underlying disease. The 
‘community’ PPMs such as Haemophilus influenzae, 
Staphylococcus aureus, Streptococcus pneumoniae and 
Eschericliia coli are carried by previously healthy 
individuals whilst ‘hospital’ PPMs, the typical 
opportunistic aerobic Gram-negative bacdli (AGNB), 
including Klebsiella, Enterobacter, Serratia, Citrobacter and 
Pseudomonas species, are carried by people with an 
underlying pathology, either chronic, such as diabetes, 
or acute, including pancreatitis or burns. Recent work 
shows that the carriage rate of these opportunistic 
AGNB was increased to 50% in a mixed intensive care 
population with an average APACHE I1 score of 15 
[3,41. 
The normal indigenous flora in the oropharynx 
and gut characterized by a low IPI is vital for normal 
physiology [5]. It produces vitamins [6] ,  contributes to 
the renewal of throat and gut mucosa [7] and promotes 
reabsorption of water [8]. Moreover, normal anaerobic 
flora is important in controlling acquisition, carriage 
and subsequent overgrowth of the 14 aerobic potential 
pathogens [9]. Overgrowth has recently been 
recognized to be an independent risk factor for colon- 
ization and infection of internal organs [lo]; trans- 
mission via hands [ l l ] ;  and the presence of resistant 
mutants amongst potential pathogens [12]. Once a 
particular PPM reaches the level of 1 O5 colony-forming 
units/mL in saliva, the chance of isolating the identical 
microorganism from the lower airways is as high as 50% 
[ 101. The higher the salivary and fecal concentrations 
of methicillin-resistant Staphylococcus aureus (MRSA), 
the higher the risk of its spread [ 1 11. In order to contain 
a resistant mutant, a bacterial population of at least 10’ 
microorganisms is required [12]. Therefore, to prevent 
overgrowth we must respect the microbial ecology of 
normal flora and not use antibiotics which suppress 
normal flora. We should only use agents that are active 
against potential pathogens whilst sparing indigenous 
physiologic flora. This sort of antibiotic is a narrow- 
spectrum antibiotic by current definition, only active 
against potential pathogens. Broad-spectrum antibiotics 
kill both potential pathogens and also the normal flora. 
Flucloxacillin is broader than cephradine, from an 
ecological point ofview [13,14]. In addition to exerting 
a selection pressure on MRSA, flucloxacillin may 
promote concomitant overgrowth of MRSA and 
encourage dissemination. It is not surprising that more 
MRSA than ever are reported. Yet we continue to use 
the so-called narrow-spectrum antibiotic flucloxacillin. 
We believe that restoration of the microbial ecology 
may be a prerequisite for the control of the emergence 
of serious resistance problems. However, that approach 
implies a careful withdrawal of popular antibiotics 
such as (3-lactams and (3-lactamase inhibitors, fluoro- 
quinolones and carbapenems known to have an impact 
on the ecology. But do most patients need them? 
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